清潔能源燃料 CLNE 深 滬
已收盤 10-24 16:00:00 美东时间
3.06
+0.200
+6.99%
華盛通- 最 高3.07
- 今 開2.90
- 成交量 213.12万股
- 最 低 2.89
- 昨 收 2.86
- 總市值 6.70亿
- 52周最高 3.67
- 市盈率 靜 --
- 換手率 0.97%
- 52周最低 1.30
- 委 比 -51.78%
- 總股本 2.19亿
- 歷史最高 24.75
- 量 比 1.80
- 振 幅 6.29%
- 歷史最低 1.05
- 每 手 1
- 風險率 0.55%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Clean Energy Technologies, Inc. Regains Compliance with Nasdaq Listing Requirements
Clean Energy Technologies, Inc. (CETY) has regained compliance with Nasdaq's minimum bid price requirement, maintaining a closing bid price of $1.00 or higher for ten consecutive trading days. This achievement reflects the company's operational progress and financial discipline. CETY is now positioned to accelerate growth across its renewable energy projects, including waste-to-energy and power generation initiatives. The milestone comes as the c...
10-23 13:15
Clean Energy Fuels Unveils New Natural Gas Truck To Cut Emissions and Fuel Costs
Clean Energy Fuels Corp. (NASDAQ:CLNE), the largest provider of renewable natural gas (RNG) for the transportation industry, has announced the launch of its second heavy-duty truck demo program, featuring the 2026
10-22 18:34
Shares of solar, wind and clean energy stocks are trading lower following reports suggesting President Trump may cancel an additional $12 billion of funding for clean energy projects.
Shares of solar, wind and clean energy stocks are trading lower following repor...
10-08 02:28
Clean Energy Wins $11.3M Deal To Build Second Hydrogen Bus Fueling Station For Foothill Transit
Clean Energy Fuels Corp.
09-25 18:33
Clene Presents New Clinical Data at ECTRIMS 2025 Meeting Demonstrating CNM-Au8® Improves Brain Energy Metabolism in Multiple Sclerosis Patients
Clene Inc. presented late-breaking clinical data at the 41st ECTRIMS Congress, showing that CNM-Au8 improved brain energy metabolism in MS and Parkinson’s disease patients by increasing the NAD+/NADH ratio. FDA expressed openness to considering cognition as a primary endpoint for broader treatment effects. Results demonstrate bioenergetic failure’s role in neurodegeneration and suggest CNM-Au8 may slow disability progression. Treatment was safe a...
09-25 12:00
Clean Energy Fuels Announces Board Member Changes
Clean Energy Fuels ( ($CLNE) ) has shared an announcement. On September 10, 202...
09-12 04:39
Clene Presents Preclinical Data Supporting CNM-Au8® for the Treatment of Parkinson’s Disease
Clene Inc. announced new preclinical data showing CNM-Au8 improved mitochondrial health, reduced inflammation, restored cellular metabolism, and normalized gene expression in Parkinson’s disease (PD) dopaminergic neuron models derived from patients. These findings, presented at the Michael J. Fox Foundation H2 Therapeutics Stewardship Meeting, further support CNM-Au8’s potential as a PD treatment. The study also demonstrated CNM-Au8’s favorable s...
09-04 12:30
Clene to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Clene Inc. and its subsidiary Clene Nanomedicine Inc. announced they will present at the H.C. Wainwright 27th Annual Global Investment Conference in New York City on September 8-10, 2025, with a virtual presentation available on September 5. Clene focuses on treating neurodegenerative diseases like ALS and MS through its lead candidate CNM-Au8®, targeting mitochondrial function and reducing oxidative stress. Investors can schedule 1x1 meetings vi...
09-02 12:00
Clean Energy Fuels Q2 2025 Earnings Call Highlights
Clean Energy Fuels (($CLNE)) has held its Q2 earnings call. Read on for the mai...
08-12 08:55
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
